- Corporate Officers - S
- Schoeneck James A
Insider Trading History of Schoeneck James A
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Schoeneck James A since 2015.
This trader's CIK number is 1420987.
At the time of last reporting, Schoeneck James A was the Officer of Calidi Biotherapeutics, Inc.. (stock ticker symbol CLDI).
Also see all insider trading activities at Calidi Biotherapeutics, Inc..
Note that in the past
Schoeneck James A also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Fibrogen Inc (FGEN) by Schoeneck James A
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2025 | FGEN | 323,567 | $224,534 | 0 | $0 | 0 | $0 |
2023 | FGEN | 0 | $0 | 7,100 | $127,984 | 0 | $0 |
2021 | FGEN | 0 | $0 | 0 | $0 | 6,000 | $58,650 |
2020 | FGEN | 0 | $0 | 0 | $0 | 6,000 | $35,700 |
2019 | FGEN | 0 | $0 | 10,000 | $516,280 | 24,000 | $73,800 |
2018 | FGEN | 0 | $0 | 12,000 | $780,000 | 36,000 | $368,111 |
Yearly summary of insider trading at Assertio Therapeutics, Inc (DEPO) by Schoeneck James A
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2016 | DEPO | 0 | $0 | 0 | $0 | 30,483 | $165,217 |
2015 | DEPO | 0 | $0 | 0 | $0 | 115,605 | $761,579 |
Yearly summary of insider trading at Calidi Biotherapeutics, Inc. (CLDI) by Schoeneck James A
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2025 | CLDI | 75,000 | $150,000 | 0 | $0 | 0 | $0 |
2024 | CLDI | 0 | $0 | 0 | $0 | 548,000 | $109,600 |
Insider trading activities at 3 companies by Schoeneck James A:
1. Fibrogen Inc (FGEN)
2. Assertio Therapeutics, Inc (DEPO)
3. Calidi Biotherapeutics, Inc. (CLDI)
Table 1. Insider trading of Fibrogen Inc (FGEN) by Schoeneck James A
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2025-06-30 | FGEN | Buy | 23,567 | 5.07 | 119,484 |
2025-03-20 | FGEN | Buy | 250,000 | .35 | 88,000 |
2025-03-21 | FGEN | Buy | 50,000 | .34 | 17,050 |
2023-06-07 | FGEN | Sale | 7,100 | 18.03 | 127,984 |
2021-01-04 | FGEN | Option Ex | 6,000 | 9.78 | 58,650 |
2020-08-20 | FGEN | Option Ex | 6,000 | 5.95 | 35,700 |
2019-05-28 | FGEN | Option Ex | 14,000 | 3.20 | 44,800 |
2019-05-07 | FGEN | Option Ex | 2,000 | 2.90 | 5,800 |
2019-05-07 | FGEN | Sale | 2,000 | 47.24 | 94,490 |
2019-04-08 | FGEN | Sale | 2,000 | 52.90 | 105,800 |
2019-04-08 | FGEN | Option Ex | 2,000 | 2.90 | 5,800 |
2019-03-07 | FGEN | Option Ex | 2,000 | 2.90 | 5,800 |
2019-03-07 | FGEN | Sale | 2,000 | 54.92 | 109,850 |
2019-02-07 | FGEN | Option Ex | 2,000 | 2.90 | 5,800 |
2019-02-07 | FGEN | Sale | 2,000 | 57.17 | 114,340 |
2019-01-07 | FGEN | Sale | 2,000 | 45.90 | 91,800 |
2019-01-07 | FGEN | Option Ex | 2,000 | 2.90 | 5,800 |
2018-10-30 | FGEN | Option Ex | 24,000 | 13.89 | 333,312 |
2018-07-03 | FGEN | Sale | 7,639 | 65.00 | 496,535 |
2018-07-03 | FGEN | Option Ex | 7,639 | 2.90 | 22,153 |
2018-06-22 | FGEN | Option Ex | 4,361 | 2.90 | 12,646 |
2018-06-22 | FGEN | Sale | 4,361 | 65.00 | 283,465 |
Table 2. Insider trading of Assertio Therapeutics, Inc (DEPO) by Schoeneck James A
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2016-03-18 | DEPO | Option Ex | 30,483 | 5.42 | 165,217 |
2015-12-28 | DEPO | Option Ex | 6,365 | 6.11 | 38,890 |
2015-09-29 | DEPO | Option Ex | 63,561 | 6.44 | 409,332 |
2015-05-12 | DEPO | Option Ex | 45,679 | 6.86 | 313,357 |
Table 3. Insider trading of Calidi Biotherapeutics, Inc. (CLDI) by Schoeneck James A
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2025-08-21 | CLDI | Buy | 75,000 | 2.00 | 150,000 |
2024-06-03 | CLDI | Option Ex | 548,000 | .20 | 109,600 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Schoeneck James A
(Officer of Calidi Biotherapeutics, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.